Is HCAT or LFMD more undervalued in 2026?

CirclFi compares Health Catalyst, Inc (HCAT) and LifeMD, Inc. (LFMD) using 13 institutional-grade valuation models. HCAT has a Quality of Company score of 5.9/10 while LFMD scores 7.7/10.

Which is a better buy — HCAT or LFMD?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do HCAT and LFMD valuations compare?

HCAT at $1.40 and LFMD at $4.59 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

HCAT vs LFMD Valuation Comparison 2026 — Intrinsic Value Analysis

HCAT

Health Information Services

Health Catalyst, Inc

Quality

5.9

out of 10

Value Trap

WARN

Price

$1.40

Last close

Models

11/13

Active

LFMD

Health Information Services

LifeMD, Inc.

Quality

7.7

out of 10

Value Trap

SAFE

Price

$4.59

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	HCAT Fair Value	HCAT Upside	LFMD Fair Value	LFMD Upside
Bayesian DCF	Intrinsic	$4.65	+274.7%	$1.77	-61.4%
Earnings Power Value	Intrinsic	—	—	$3.89	-22.3%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.29	-79.9%	—	—
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for HCAT vs LFMD — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HCAT vs LFMD — Which Stock Is More Undervalued?

LFMD scores higher with a 7.7/10 quality rating vs HCAT's 5.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Health Catalyst, Inc (HCAT) and LifeMD, Inc. (LFMD) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HCAT currently trades at $1.40 with a QOC of 5.9/10, while LFMD trades at $4.59 with a QOC of 7.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).